Wednesday, March 20, 2024 9:26:16 AM
@sohminc
The company is actively exploring, negotiating, and collaborating with several Japanese companies to expand its business.
This expansion includes the utilization of gene-editing technology called ABBIE, as well as licensing opportunities.
The management remains committed to maximizing benefits for the company and its stakeholders.”
If you need further refinement or have any additional requests, feel free to ask!
$SHMN
#GeneEditing
#pharmaceutical
Recent SHMN News
- Gene Editing Company Joins Forces to Advance Gene Therapy • AllPennyStocks.com • 04/01/2024 03:46:00 PM
FEATURED Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • May 17, 2024 11:00 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM
Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform • AVAI • May 16, 2024 8:00 AM